Genentech

Genentech: Carmot Therapeutics is a biopharmaceutical company based in the United States. The company is focused on developing innovative treatments for obesity, type 1 diabetes, and type 2 diabetes, with three clinical-stage assets in its pipeline. Carmot Therapeutics is currently conducting clinical trials to evaluate the safety, tolerability, and efficacy of its GLP-1/GIP receptor agonists and GLP-1 receptor agonist.